Free Trial

Plus Therapeutics (PSTV) SEC Filings & 10K Form

Plus Therapeutics logo
$0.65 0.00 (-0.34%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$0.62 -0.02 (-3.84%)
As of 05/2/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Plus Therapeutics SEC Filings

DateFilerForm TypeView
05/02/2025
3:05 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
9:06 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form DEFA14A
04/10/2025
3:11 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form DEF 14A
04/04/2025
3:35 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/01/2025
4:30 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form PRER14A
03/31/2025
3:01 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form RW
03/18/2025
3:17 PM
PLUS THERAPEUTICS, INC. (Subject)
Plus Therapeutics (Subject)
S.H.N. Financial Investments Ltd. (Filed by)
Form SCHEDULE 13G
03/14/2025
4:22 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form PRE 14A
03/10/2025
6:33 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 424B3
03/10/2025
6:30 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
4:30 PM
Petersen Greg (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:30 PM
HEDRICK MARC H (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:30 PM
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
van Es-Johansson An (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:30 PM
Lenk Robert P (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:30 PM
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Sims Andrew John Hugh MacIntyre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:30 PM
Clowes Howard (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:30 PM
Hawkins Richard J (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
6:30 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
6:32 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 424B3
02/10/2025
7:27 AM
HIRSCHMAN ORIN (Filed by)
PLUS THERAPEUTICS, INC. (Subject)
Plus Therapeutics (Subject)
Form SCHEDULE 13G/A
11/01/2024
7:25 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
7:30 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 424B3
10/04/2024
3:11 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/17/2024
6:00 AM
Hawkins Richard J (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
6:00 AM
Hawkins Richard J (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:04 AM
Petersen Greg (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:04 AM
Clowes Howard (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:30 PM
HEDRICK MARC H (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:30 PM
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Sims Andrew John Hugh MacIntyre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:30 PM
Petersen Greg (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:30 PM
Clowes Howard (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:30 PM
Hawkins Richard J (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:30 PM
Lenk Robert P (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:30 PM
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
van Es-Johansson An (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
5:02 AM
HEDRICK MARC H (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
5:02 AM
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Sims Andrew John Hugh MacIntyre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
3:47 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
3:52 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 424B3
08/23/2024
3:31 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/15/2024
3:50 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:53 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 424B3
Virtually Limitless Energy? (Ad)

A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts. This obscure company could be at the center of the next trillion-dollar energy revolution.

One company’s discovery could change power forever
08/14/2024
3:48 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 424B3
07/12/2024
3:40 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form DEFA14A
07/10/2024
11:12 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form ARS
07/10/2024
6:00 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form DEF 14A
06/24/2024
11:15 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form EFFECT
06/24/2024
4:12 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 424B3
06/07/2024
4:02 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/05/2024
6:26 AM
HIRSCHMAN ORIN (Filed by)
PLUS THERAPEUTICS, INC. (Subject)
Plus Therapeutics (Subject)
Form SC 13G
06/04/2024
4:16 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
6:00 AM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
6:30 AM
Lenk Robert P (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
6:30 AM
Hawkins Richard J (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
6:30 AM
Clowes Howard (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
6:30 AM
Petersen Greg (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
6:30 AM
HEDRICK MARC H (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
6:30 AM
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Sims Andrew John Hugh MacIntyre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:20 PM
PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PSTV) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners